# Efficacy of Fructose Metabolizing Enzymatic Product in Fructose Malabsorption

> **NCT00916487** · NA · COMPLETED · sponsor: **Sciotec Diagnostic Technologies GmbH** · enrollment: 65 (actual)

## Conditions studied

- Fructose Malabsorption

## Interventions

- **DIETARY_SUPPLEMENT:** Fructosin

## Key facts

- **NCT ID:** NCT00916487
- **Lead sponsor:** Sciotec Diagnostic Technologies GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-05
- **Final completion:** 2010-08
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2010-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00916487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00916487, "Efficacy of Fructose Metabolizing Enzymatic Product in Fructose Malabsorption". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00916487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*